Category: Firm News

W&L Investigates Rising Costs of Insulin

The pricing of insulin by three major drug companies is being investigated by Weitz & Luxenberg

Weitz & Luxenberg is investigating the pricing of insulin by three major drug companies — Eli Lilly, Novo Nordisk, and Sanofi — following a report that the cost of the drug has nearly tripled since 2002. A separate analysis found that prices from two manufacturers rose in tandem during a six-year period.“Rising insulin costs have significant financial…

Read More

W&L Secures Pro Bono Decision Limiting Solitary Confinement for Death Row Inmates Who Have Been Granted New Sentences

W&L Secures Pro bono decision for death row inmates who have been granted new sentences

Weitz & Luxenberg has secured a decision in the U.S. Court of Appeals for the Third Circuit that recognizes a constitutionally protected liberty interest that prevents the State of Pennsylvania from indefinitely housing death row inmates in solitary confinement after they have been granted a resentencing hearing. The decision ensures that these prisoners will not…

Read More

Nurse Assist IV Syringes Linked to Dangerous Infections

IV syringes assisted by nurses have been linked to dangerous infections.

Weitz & Luxenberg is currently accepting cases from people who became seriously ill or who had relatives die after they developed bloodstream infections due to Burkholderia cepacia (B. cepacia) from certain contaminated intravenous (IV) syringes. The devices in question were Saline Flush IV Syringes manufactured by Nurse Assist, Inc., a company based in Haltom City,…

Read More

Looking For Legal Help?

We would feel privileged to assist you. For a free case review, please contact us today

Get Yours Now